Very early infective endocarditis after transcatheter aortic valve replacement

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Very early infective endocarditis after transcatheter aortic valve replacement. / Panagides, Vassili; Abdel-Wahab, Mohamed; Mangner, Norman; Durand, Eric; Ihlemann, Nikolaj; Urena, Marina; Pellegrini, Costanza; Giannini, Francesco; Scislo, Piotr; Huczek, Zenon; Landt, Martin; Auffret, Vincent; Sinning, Jan Malte; Cheema, Asim N.; Nombela-Franco, Luis; Chamandi, Chekrallah; Campelo-Parada, Francisco; Munoz-Garcia, Erika; Herrmann, Howard C.; Testa, Luca; Kim, Won Keun; Eltchaninoff, Helene; Søndergaard, Lars; Himbert, Dominique; Husser, Oliver; Latib, Azeem; Le Breton, Hervé; Servoz, Clement; Gervais, Philippe; del Val, David; Linke, Axel; Crusius, Lisa; Thiele, Holger; Holzhey, David; Rodés-Cabau, Josep.

I: Clinical Research in Cardiology, Bind 111, 2022, s. 1087–1097.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Panagides, V, Abdel-Wahab, M, Mangner, N, Durand, E, Ihlemann, N, Urena, M, Pellegrini, C, Giannini, F, Scislo, P, Huczek, Z, Landt, M, Auffret, V, Sinning, JM, Cheema, AN, Nombela-Franco, L, Chamandi, C, Campelo-Parada, F, Munoz-Garcia, E, Herrmann, HC, Testa, L, Kim, WK, Eltchaninoff, H, Søndergaard, L, Himbert, D, Husser, O, Latib, A, Le Breton, H, Servoz, C, Gervais, P, del Val, D, Linke, A, Crusius, L, Thiele, H, Holzhey, D & Rodés-Cabau, J 2022, 'Very early infective endocarditis after transcatheter aortic valve replacement', Clinical Research in Cardiology, bind 111, s. 1087–1097. https://doi.org/10.1007/s00392-022-01998-0

APA

Panagides, V., Abdel-Wahab, M., Mangner, N., Durand, E., Ihlemann, N., Urena, M., Pellegrini, C., Giannini, F., Scislo, P., Huczek, Z., Landt, M., Auffret, V., Sinning, J. M., Cheema, A. N., Nombela-Franco, L., Chamandi, C., Campelo-Parada, F., Munoz-Garcia, E., Herrmann, H. C., ... Rodés-Cabau, J. (2022). Very early infective endocarditis after transcatheter aortic valve replacement. Clinical Research in Cardiology, 111, 1087–1097. https://doi.org/10.1007/s00392-022-01998-0

Vancouver

Panagides V, Abdel-Wahab M, Mangner N, Durand E, Ihlemann N, Urena M o.a. Very early infective endocarditis after transcatheter aortic valve replacement. Clinical Research in Cardiology. 2022;111:1087–1097. https://doi.org/10.1007/s00392-022-01998-0

Author

Panagides, Vassili ; Abdel-Wahab, Mohamed ; Mangner, Norman ; Durand, Eric ; Ihlemann, Nikolaj ; Urena, Marina ; Pellegrini, Costanza ; Giannini, Francesco ; Scislo, Piotr ; Huczek, Zenon ; Landt, Martin ; Auffret, Vincent ; Sinning, Jan Malte ; Cheema, Asim N. ; Nombela-Franco, Luis ; Chamandi, Chekrallah ; Campelo-Parada, Francisco ; Munoz-Garcia, Erika ; Herrmann, Howard C. ; Testa, Luca ; Kim, Won Keun ; Eltchaninoff, Helene ; Søndergaard, Lars ; Himbert, Dominique ; Husser, Oliver ; Latib, Azeem ; Le Breton, Hervé ; Servoz, Clement ; Gervais, Philippe ; del Val, David ; Linke, Axel ; Crusius, Lisa ; Thiele, Holger ; Holzhey, David ; Rodés-Cabau, Josep. / Very early infective endocarditis after transcatheter aortic valve replacement. I: Clinical Research in Cardiology. 2022 ; Bind 111. s. 1087–1097.

Bibtex

@article{a486a4a1095644339f51262656d697a3,
title = "Very early infective endocarditis after transcatheter aortic valve replacement",
abstract = "Background: Scarce data exist about early infective endocarditis (IE) after trans-catheter aortic valve replacement (TAVR). Objective: The objective was to evaluate the characteristics, management, and outcomes of very early (VE) IE (≤ 30 days) after TAVR. Methods: This multicenter study included a total of 579 patients from the Infectious Endocarditis after TAVR International Registry who had the diagnosis of definite IE following TAVR. Results: Ninety-one patients (15.7%) had VE-IE. Factors associated with VE-IE (vs. delayed IE (D-IE)) were female gender (p = 0.047), the use of self-expanding valves (p < 0.001), stroke (p = 0.019), and sepsis (p < 0.001) after TAVR. Staphylococcus aureus was the main pathogen among VE-IE patients (35.2% vs. 22.7% in the D-IE group, p = 0.012), and 31.2% of Staphylococcus aureus infections in the VE-IE group were methicillin-resistant (vs. 14.3% in the D-IE group, p = 0.001). The second-most common germ was enterococci (34.1% vs. 24.4% in D-IE cases, p = 0.05). VE-IE was associated with very high in-hospital (44%) and 1-year (54%) mortality rates. Acute renal failure following TAVR (p = 0.001) and the presence of a non-enterococci pathogen (p < 0.001) were associated with an increased risk of death. Conclusion: A significant proportion of IE episodes following TAVR occurs within a few weeks following the procedure and are associated with dismal outcomes. Some baseline and TAVR procedural factors were associated with VE-IE, and Staphylococcus aureus and enterococci were the main causative pathogens. These results may help to select the more appropriate antibiotic prophylaxis in TAVR procedures and guide the initial antibiotic therapy in those cases with a clinical suspicion of IE. Graphical abstract: Very early infective endocarditis after trans-catheter aortic valve replacement. VE-IE indicates very early infective endocarditis (≤30 days post TAVR). D-IE indicates delayed infective endocarditis. [Figure not available: see fulltext.].",
keywords = "Anti-bio-prophylaxis, Healthcare-associated infection, Heart surgery, Infective endocarditis, TAVR",
author = "Vassili Panagides and Mohamed Abdel-Wahab and Norman Mangner and Eric Durand and Nikolaj Ihlemann and Marina Urena and Costanza Pellegrini and Francesco Giannini and Piotr Scislo and Zenon Huczek and Martin Landt and Vincent Auffret and Sinning, {Jan Malte} and Cheema, {Asim N.} and Luis Nombela-Franco and Chekrallah Chamandi and Francisco Campelo-Parada and Erika Munoz-Garcia and Herrmann, {Howard C.} and Luca Testa and Kim, {Won Keun} and Helene Eltchaninoff and Lars S{\o}ndergaard and Dominique Himbert and Oliver Husser and Azeem Latib and {Le Breton}, Herv{\'e} and Clement Servoz and Philippe Gervais and {del Val}, David and Axel Linke and Lisa Crusius and Holger Thiele and David Holzhey and Josep Rod{\'e}s-Cabau",
note = "Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.",
year = "2022",
doi = "10.1007/s00392-022-01998-0",
language = "English",
volume = "111",
pages = "1087–1097",
journal = "Clinical Research in Cardiology",
issn = "1861-0684",
publisher = "Springer Medizin",

}

RIS

TY - JOUR

T1 - Very early infective endocarditis after transcatheter aortic valve replacement

AU - Panagides, Vassili

AU - Abdel-Wahab, Mohamed

AU - Mangner, Norman

AU - Durand, Eric

AU - Ihlemann, Nikolaj

AU - Urena, Marina

AU - Pellegrini, Costanza

AU - Giannini, Francesco

AU - Scislo, Piotr

AU - Huczek, Zenon

AU - Landt, Martin

AU - Auffret, Vincent

AU - Sinning, Jan Malte

AU - Cheema, Asim N.

AU - Nombela-Franco, Luis

AU - Chamandi, Chekrallah

AU - Campelo-Parada, Francisco

AU - Munoz-Garcia, Erika

AU - Herrmann, Howard C.

AU - Testa, Luca

AU - Kim, Won Keun

AU - Eltchaninoff, Helene

AU - Søndergaard, Lars

AU - Himbert, Dominique

AU - Husser, Oliver

AU - Latib, Azeem

AU - Le Breton, Hervé

AU - Servoz, Clement

AU - Gervais, Philippe

AU - del Val, David

AU - Linke, Axel

AU - Crusius, Lisa

AU - Thiele, Holger

AU - Holzhey, David

AU - Rodés-Cabau, Josep

N1 - Publisher Copyright: © 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

PY - 2022

Y1 - 2022

N2 - Background: Scarce data exist about early infective endocarditis (IE) after trans-catheter aortic valve replacement (TAVR). Objective: The objective was to evaluate the characteristics, management, and outcomes of very early (VE) IE (≤ 30 days) after TAVR. Methods: This multicenter study included a total of 579 patients from the Infectious Endocarditis after TAVR International Registry who had the diagnosis of definite IE following TAVR. Results: Ninety-one patients (15.7%) had VE-IE. Factors associated with VE-IE (vs. delayed IE (D-IE)) were female gender (p = 0.047), the use of self-expanding valves (p < 0.001), stroke (p = 0.019), and sepsis (p < 0.001) after TAVR. Staphylococcus aureus was the main pathogen among VE-IE patients (35.2% vs. 22.7% in the D-IE group, p = 0.012), and 31.2% of Staphylococcus aureus infections in the VE-IE group were methicillin-resistant (vs. 14.3% in the D-IE group, p = 0.001). The second-most common germ was enterococci (34.1% vs. 24.4% in D-IE cases, p = 0.05). VE-IE was associated with very high in-hospital (44%) and 1-year (54%) mortality rates. Acute renal failure following TAVR (p = 0.001) and the presence of a non-enterococci pathogen (p < 0.001) were associated with an increased risk of death. Conclusion: A significant proportion of IE episodes following TAVR occurs within a few weeks following the procedure and are associated with dismal outcomes. Some baseline and TAVR procedural factors were associated with VE-IE, and Staphylococcus aureus and enterococci were the main causative pathogens. These results may help to select the more appropriate antibiotic prophylaxis in TAVR procedures and guide the initial antibiotic therapy in those cases with a clinical suspicion of IE. Graphical abstract: Very early infective endocarditis after trans-catheter aortic valve replacement. VE-IE indicates very early infective endocarditis (≤30 days post TAVR). D-IE indicates delayed infective endocarditis. [Figure not available: see fulltext.].

AB - Background: Scarce data exist about early infective endocarditis (IE) after trans-catheter aortic valve replacement (TAVR). Objective: The objective was to evaluate the characteristics, management, and outcomes of very early (VE) IE (≤ 30 days) after TAVR. Methods: This multicenter study included a total of 579 patients from the Infectious Endocarditis after TAVR International Registry who had the diagnosis of definite IE following TAVR. Results: Ninety-one patients (15.7%) had VE-IE. Factors associated with VE-IE (vs. delayed IE (D-IE)) were female gender (p = 0.047), the use of self-expanding valves (p < 0.001), stroke (p = 0.019), and sepsis (p < 0.001) after TAVR. Staphylococcus aureus was the main pathogen among VE-IE patients (35.2% vs. 22.7% in the D-IE group, p = 0.012), and 31.2% of Staphylococcus aureus infections in the VE-IE group were methicillin-resistant (vs. 14.3% in the D-IE group, p = 0.001). The second-most common germ was enterococci (34.1% vs. 24.4% in D-IE cases, p = 0.05). VE-IE was associated with very high in-hospital (44%) and 1-year (54%) mortality rates. Acute renal failure following TAVR (p = 0.001) and the presence of a non-enterococci pathogen (p < 0.001) were associated with an increased risk of death. Conclusion: A significant proportion of IE episodes following TAVR occurs within a few weeks following the procedure and are associated with dismal outcomes. Some baseline and TAVR procedural factors were associated with VE-IE, and Staphylococcus aureus and enterococci were the main causative pathogens. These results may help to select the more appropriate antibiotic prophylaxis in TAVR procedures and guide the initial antibiotic therapy in those cases with a clinical suspicion of IE. Graphical abstract: Very early infective endocarditis after trans-catheter aortic valve replacement. VE-IE indicates very early infective endocarditis (≤30 days post TAVR). D-IE indicates delayed infective endocarditis. [Figure not available: see fulltext.].

KW - Anti-bio-prophylaxis

KW - Healthcare-associated infection

KW - Heart surgery

KW - Infective endocarditis

KW - TAVR

U2 - 10.1007/s00392-022-01998-0

DO - 10.1007/s00392-022-01998-0

M3 - Journal article

C2 - 35262756

AN - SCOPUS:85128495977

VL - 111

SP - 1087

EP - 1097

JO - Clinical Research in Cardiology

JF - Clinical Research in Cardiology

SN - 1861-0684

ER -

ID: 314073322